Search

everythinglearnresearchcommunity

for

Search:↓

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

The conclusion is that there's no significant link between male pattern baldness and the severity of coronary artery disease.

Using a smaller syringe causes less pain when giving an injection.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

Red and near-infrared light-emitting fabric may help improve psoriasis, PMLE, and alopecia areata.

Better nutrition may reduce fecal incontinence in stroke patients by lowering inflammation and improving antioxidant levels.

Histopathology is not reliable for detecting early fibrosis in traction alopecia or for showing how severe it is.

Hair manganese may relate to cardiometabolic health, not coronary artery disease severity.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

DLQI is a reasonable quality-of-life measure for alopecia patients, but more research is needed.

The AI system HairComb accurately scores hair loss severity, matching dermatologist assessments.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Wigs significantly improve the well-being of people with severe hair loss.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

PRP treatment may help with alopecia areata, especially in newer cases.

Photobiomodulation therapy effectively promotes hair regrowth and improves quality of life in alopecia areata without side effects.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

The combination of calcipotriol and PRP is the most effective treatment for alopecia areata.

Triamcinolone is more effective than methotrexate for treating localized alopecia areata.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

PRP is an effective and safe treatment for hair loss in women.

Combining tacrolimus with excimer light is more effective for treating alopecia areata than using excimer light alone.

Calcipotriol cream can effectively and safely treat mild-to-moderate patchy hair loss.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.